Steve Lianoglou
Steve Lianoglou
Bioinformatics Scientist, Denali Therapeutics
Adresse e-mail validée de dnli.com
Titre
Citée par
Citée par
Année
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
S Mariathasan, SJ Turley, D Nickles, A Castiglioni, K Yuen, Y Wang, ...
Nature 554 (7693), 544-548, 2018
13332018
Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression
S Lianoglou, V Garg, JL Yang, CS Leslie, C Mayr
Genes & Development 27 (21), 2380-2396, 2013
3092013
Reproducible pharmacogenomic profiling of cancer cell line panels
PM Haverty, E Lin, J Tan, Y Yu, B Lam, S Lianoglou, RM Neve, S Martin, ...
Nature 533 (7603), 333-337, 2016
1972016
Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice
J Lau, J Cheung, A Navarro, S Lianoglou, B Haley, K Totpal, L Sanders, ...
Nature communications 8 (1), 1-11, 2017
1872017
Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs
SM Park, RP Deering, Y Lu, P Tivnan, S Lianoglou, F Al-Shahrour, ...
Journal of Experimental Medicine 211 (1), 71-87, 2014
1172014
Genome-wide identification of miRNA targets by PAR-CLIP
M Hafner, S Lianoglou, T Tuschl, D Betel
Methods 58 (2), 94-105, 2012
1062012
TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge
AA Nugent, K Lin, B Van Lengerich, S Lianoglou, L Przybyla, SS Davis, ...
Neuron 105 (5), 837-854. e9, 2020
1022020
Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1–TFE3 fusion oncoprotein
R Kobos, M Nagai, M Tsuda, MY Merl, T Saito, M Laé, Q Mo, A Olshen, ...
The Journal of Pathology, 2013
622013
Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration
YW Lim, H Chen-Harris, O Mayba, S Lianoglou, A Wuster, T Bhangale, ...
Proceedings of the National Academy of Sciences 115 (50), E11701-E11710, 2018
602018
A predictive model of the oxygen and heme regulatory network in yeast
A Kundaje, X Xin, C Lan, S Lianoglou, M Zhou, L Zhang, C Leslie
PLoS computational biology 4 (11), e1000224, 2008
552008
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
Y Kong, CM Rose, AA Cass, AG Williams, M Darwish, S Lianoglou, ...
Nature communications 10 (1), 1-14, 2019
462019
Testosterone is an endogenous regulator of BAFF and splenic B cell number
AS Wilhelmson, ML Rodriguez, A Stubelius, P Fogelstrand, I Johansson, ...
Nature communications 9 (1), 1-13, 2018
322018
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice
JC Ullman, A Arguello, JA Getz, A Bhalla, CS Mahon, J Wang, T Giese, ...
Science Translational Medicine 12 (545), 2020
312020
Learning regulatory programs that accurately predict differential expression with MEDUSA
A Kundaje, S Lianoglou, X Li, D Quigley, M Arias, CH Wiggins, L Zhang, ...
Annals of the New York Academy of Sciences 1115 (1), 178-202, 2007
192007
Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes
TL Arenzana, S Lianoglou, A Seki, C Eidenschenk, T Cheung, ...
Science immunology 3 (22), 2018
122018
The immunoglobulin superfamily receptome defines cancer-relevant networks associated with clinical outcome
E Verschueren, B Husain, K Yuen, Y Sun, S Paduchuri, Y Senbabaoglu, ...
Cell 182 (2), 329-344. e19, 2020
112020
Methods of treating cancer using pd-1 axis binding antagonists and il-17 binding antagonists
J Grogan, X Yuanyuan, P Caplazi, S Lianoglou, J Hackney, EY Chiang
US Patent App. 15/448,437, 2017
32017
Transposable element exprssion in tumors is associated with immune infiltration and increased antigenicity
Y Kong, C Rose, AA Cass, M Darwish, S Lianoglou, PM Haverty, AJ Tong, ...
bioRxiv, 388215, 2018
22018
Pre-existing T cell immunity, mutational burden and stromal TGF-beta signaling drives clinical responses to atezolizumab in locally advanced or metastatic urothelial carcinoma …
S Mariathasan, SJ Turley, D Nickles, Y Wang, EE Kadel III, H Koeppen, ...
JOURNAL FOR IMMUNOTHERAPY OF CANCER 5, 2017
22017
Fibrillar Aβ causes profound microglial metabolic perturbations in a novel APP knock-in mouse model
D Xia, S Lianoglou, T Sandmann, M Calvert, JH Suh, E Thomsen, ...
bioRxiv, 2021
12021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20